Sector
PharmaceuticalsOpen
₹128.95Prev. Close
₹124.1Turnover(Lac.)
₹0.46Day's High
₹128.95Day's Low
₹118.852 Week's High
₹15452 Week's Low
₹55.1Book Value
₹87.6Face Value
₹10Mkt Cap (₹ Cr.)
18.01P/E
52.65EPS
2.28Divi. Yield
014 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
29 Jul 2024
12:00 AM
AGM
Announcement Date: 29 Jul, 2024
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 1.5 | 1.5 | 1.5 | 1.5 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 11.3 | 10.1 | 10.05 | 9.49 |
Net Worth | 12.8 | 11.6 | 11.55 | 10.99 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 0 | 0 | 0 | 0 |
yoy growth (%) | 0 | 0 | 0 | 0 |
Raw materials | 0 | 0 | 0 | 0 |
As % of sales | 0 | 0 | 0 | 0 |
Employee costs | -0.17 | -0.12 | -0.19 | -0.15 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 0.36 | 0.31 | 0.49 | 0.76 |
Depreciation | -0.01 | -0.02 | -0.02 | 0 |
Tax paid | 0.19 | -0.06 | -0.07 | -0.66 |
Working capital | -4.71 | 2.21 | 0.27 | -0.14 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 0 | 0 | 0 | 0 |
Op profit growth | 21.5 | -30.47 | 41.56 | 24.33 |
EBIT growth | 17.45 | -37.12 | -35.26 | -85.69 |
Net profit growth | 123.91 | -39.76 | 312.56 | -97.85 |
| Particulars (Rupees in Crores.) | Mar-2016 |
|---|---|
Gross Sales | 0 |
Excise Duty | 0 |
Net Sales | 0 |
Other Operating Income | 0.49 |
Other Income | 0 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,663.15 | 93.33 | 3,99,045.4 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,841.15 | 82.22 | 1,81,611.04 | 667 | 0.44 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,477.3 | 24.79 | 1,19,322.68 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,339.05 | 59.72 | 1,13,003.55 | 474 | 0.18 | 2,385 | 224.34 |
Dr Reddys Laboratories Ltd DRREDDY | 1,259.2 | 19.53 | 1,05,090.54 | 1,200.7 | 0.63 | 5,546.3 | 345.76 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Executive Director & CFO
Ashok Somani
Independent Director
Toby Antony
Non Executive Director
Shanta Somani
Independent Director
Mathura Prasad Sharma
Director & Chief Executive Off
Bhavin Sheth
Independent Director
Nandkumar Pareek
Company Sec. & Compli. Officer
Unnatti Jain
Managing Director & CEO
Ruchit Mehta
Additional Director & CFO
Utsav Trivedi
Additional Director
Sarvagya Goel
Additional Director
Shilpy Chopra
Company Sec. & Compli. Officer
Bhawna Rajput
5 Kumud Apartment CHS Ltd,
Karnik Road Chikan Ghar Kalyan,
Maharashtra - 421301
Tel: 91-022-22078381/22078382
Website: http://www.thechemopharmalaboratoriesltd.com
Email: chemopharmalab@gmail.com
Unit No 1 Luthra Ind,
Andheri Kurla Road, Safed Pool Andheri(E,
Mumbai - 400 072
Tel: 91-22-2851 5606
Website: www.sharexindia.com
Email: sharexndia@vsnl.com
Summary
Chemo Pharma Laboratories Limited was established in August, 1942 and has been making Pharmaceuticals and also had diversified into bulk drugs. However due to increase in competition and flow of new d...
Read More
Reports by Chemo Pharma Laboratories Ltd
What is the Chemo Pharma Laboratories Ltd share price today?
What is the Market Cap of Chemo Pharma Laboratories Ltd?
What is the PE and PB ratio of Chemo Pharma Laboratories Ltd?
What is the 52 Week High and Low of Chemo Pharma Laboratories Ltd?
What is the CAGR of Chemo Pharma Laboratories Ltd?
What is the shareholding pattern of Chemo Pharma Laboratories Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.